CHOP collaborates with Pfizer’s Centers for Therapeutic Innovation to speed pediatric research & development
3 April 2013 | By Pfizer
CHOP and Pfizer are joining forces...
List view / Grid view
3 April 2013 | By Pfizer
CHOP and Pfizer are joining forces...
3 April 2013 | By FTI Consulting
GW has obtained a patent in the US...
3 April 2013 | By GlaxoSmithKline
Marketing authorisation for quadrivalent (four-strain) influenza vaccine...
3 April 2013 | By AstraZeneca
AstraZeneca announced that MedImmune has acquired AlphaCore Pharma, an Ann Arbor, Michigan-based biotechnology company...
2 April 2013 | By Munro & Forster
Sunovion Europe has formally changed its name from Dainippon Sumitomo Pharma Europe Ltd. (DSPE)...
2 April 2013 | By AbbVie
AbbVie announced that the European Commission has approved an extension of the EC marketing authorization for HUMIRA...
2 April 2013 | By Biogen Idec
Biogen Idec has completed its purchase of Elan Corporation’s interest in TYSABRI® (natalizumab)...
1 April 2013 | By Novartis
Novartis has never been granted an original patent for Glivec in India...
29 March 2013 | By Janssen Pharmaceuticals
The U.S. FDA has approved INVOKANA™...
29 March 2013 | By Sanofi
“This new production and development center is the largest investment ever made by Sanofi in Vietnam..."
28 March 2013 | By kdm communications
Tecan’s Infinite® M200 PRO multimode microplate readers are helping McMaster Uni...
28 March 2013 | By Pfizer
“I’m delighted the EC has approved BOSULIF..."
27 March 2013 | By BusinessWire
Shionogi Limited announced that the EMA accepted its MAA submission for ospemifene...
27 March 2013 | By kdm communications limited
Avacta Analytical has recently undertaken preformulation studies for a new targeted secretion inhibitor (TSI)...
27 March 2013 | By Merck
“We are pleased to have achieved this important milestone..."